162 related articles for article (PubMed ID: 18925659)
1. Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity.
Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T
Synapse; 2009 Jan; 63(1):7-14. PubMed ID: 18925659
[TBL] [Abstract][Full Text] [Related]
2. Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release.
Ago Y; Tanaka T; Kita Y; Tokumoto H; Takuma K; Matsuda T
Neuropharmacology; 2012 Mar; 62(4):1634-9. PubMed ID: 22001792
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression.
Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T
Neuropharmacology; 2008 Dec; 55(8):1355-63. PubMed ID: 18796307
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice.
Fujii H; Ishihama T; Ago Y; Shintani N; Kakuda M; Hashimoto H; Baba A; Matsuda T
Peptides; 2007 Sep; 28(9):1674-9. PubMed ID: 17658665
[TBL] [Abstract][Full Text] [Related]
5. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
Hall DA; Powers JP; Gulley JM
Brain Res; 2009 Dec; 1300():51-7. PubMed ID: 19733155
[TBL] [Abstract][Full Text] [Related]
6. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
7. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice.
Ago Y; Nakamura S; Kajita N; Uda M; Hashimoto H; Baba A; Matsuda T
Synapse; 2007 Sep; 61(9):757-63. PubMed ID: 17568413
[TBL] [Abstract][Full Text] [Related]
8. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study.
Steed E; Jones CA; McCreary AC
Behav Brain Res; 2011 Jun; 220(1):9-19. PubMed ID: 21262272
[TBL] [Abstract][Full Text] [Related]
10. Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice.
Yoo JH; Nam YS; Lee SY; Jang CG
Synapse; 2008 Jan; 62(1):8-13. PubMed ID: 17948891
[TBL] [Abstract][Full Text] [Related]
11. Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study.
Nagai T; Kitahara Y; Shiraki A; Hikita T; Taya S; Kaibuchi K; Yamada K
Neurosci Lett; 2010 Feb; 470(2):134-8. PubMed ID: 20045719
[TBL] [Abstract][Full Text] [Related]
12. Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice.
Kamei H; Nagai T; Nakano H; Togan Y; Takayanagi M; Takahashi K; Kobayashi K; Yoshida S; Maeda K; Takuma K; Nabeshima T; Yamada K
Biol Psychiatry; 2006 Jan; 59(1):75-84. PubMed ID: 16139811
[TBL] [Abstract][Full Text] [Related]
13. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
14. Blockade of M1 muscarinic acetylcholine receptors modulates the methamphetamine-induced psychomotor stimulant effect.
Lee KW; Tian YH; You IJ; Kwon SH; Ha RR; Lee SY; Kim HC; Jang CG
Neuroscience; 2008 Jun; 153(4):1235-44. PubMed ID: 18455881
[TBL] [Abstract][Full Text] [Related]
15. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
[TBL] [Abstract][Full Text] [Related]
16. A novel molecule 'shati' increases dopamine uptake via the induction of tumor necrosis factor-alpha in pheochromocytoma-12 cells.
Niwa M; Nitta A; Cen X; Kitaichi K; Ozaki N; Yamada K; Nabeshima T
J Neurochem; 2008 Dec; 107(6):1697-708. PubMed ID: 19014384
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.
Zhang L; Kitaichi K; Fujimoto Y; Nakayama H; Shimizu E; Iyo M; Hashimoto K
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1381-93. PubMed ID: 16839653
[TBL] [Abstract][Full Text] [Related]
18. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
Lu P; Mamiya T; Lu L; Mouri A; Niwa M; Kim HC; Zou LB; Nagai T; Yamada K; Ikejima T; Nabeshima T
Behav Brain Res; 2010 Mar; 207(2):387-93. PubMed ID: 19857526
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine-sensitized mice are accompanied by memory impairment and reduction of N-methyl-d-aspartate receptor ligand binding in the prefrontal cortex and hippocampus.
Lee KW; Kim HC; Lee SY; Jang CG
Neuroscience; 2011 Mar; 178():101-7. PubMed ID: 21256196
[TBL] [Abstract][Full Text] [Related]
20. L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression.
Yun J
Phytomedicine; 2014 Sep; 21(11):1287-91. PubMed ID: 25172791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
